Gossamer Bio, Inc. (GOSS)
0.1743
-0.03
(-14.77%)
USD |
NASDAQ |
Aug 26, 16:00
0.1778
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio Total Return Level : 0.2045 for Aug. 25, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 25, 2026 | 0.2045 |
| August 24, 2026 | 0.175 |
| August 21, 2026 | 0.1547 |
| August 20, 2026 | 0.1575 |
| August 19, 2026 | 0.1566 |
| August 18, 2026 | 0.1431 |
| August 17, 2026 | 0.14 |
| August 14, 2026 | 0.1542 |
| August 13, 2026 | 0.1703 |
| August 12, 2026 | 0.1776 |
| August 11, 2026 | 0.1818 |
| August 10, 2026 | 0.1761 |
| August 07, 2026 | 0.178 |
| August 06, 2026 | 0.1784 |
| August 05, 2026 | 0.1777 |
| August 04, 2026 | 0.1815 |
| August 03, 2026 | 0.1736 |
| July 31, 2026 | 0.1695 |
| July 30, 2026 | 0.1783 |
| July 29, 2026 | 0.2067 |
| July 28, 2026 | 0.2051 |
| July 27, 2026 | 0.1994 |
| July 24, 2026 | 0.136 |
| July 23, 2026 | 0.1425 |
| July 22, 2026 | 0.1446 |
| Date | Value |
|---|---|
| July 21, 2026 | 0.1548 |
| July 20, 2026 | 0.141 |
| July 17, 2026 | 0.1701 |
| July 16, 2026 | 0.1705 |
| July 15, 2026 | 0.1617 |
| July 14, 2026 | 0.1401 |
| July 13, 2026 | 0.1441 |
| July 10, 2026 | 0.1697 |
| July 09, 2026 | 0.175 |
| July 08, 2026 | 0.169 |
| July 07, 2026 | 0.1775 |
| July 06, 2026 | 0.1949 |
| July 02, 2026 | 0.1732 |
| July 01, 2026 | 0.1677 |
| June 30, 2026 | 0.1646 |
| June 29, 2026 | 0.164 |
| June 26, 2026 | 0.157 |
| June 25, 2026 | 0.1652 |
| June 24, 2026 | 0.169 |
| June 23, 2026 | 0.1714 |
| June 22, 2026 | 0.1642 |
| June 18, 2026 | 0.168 |
| June 17, 2026 | 0.179 |
| June 16, 2026 | 0.1677 |
| June 15, 2026 | 0.167 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| United Therapeutics Corp. | 518.53 |
| Arbutus Biopharma Corp. | 5.20 |
| Kura Oncology, Inc. | 13.59 |
| ACADIA Pharmaceuticals, Inc. | 30.57 |
| Alnylam Pharmaceuticals, Inc. | 240.08 |